Does co-location matter for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector?
No abstract is available for this item.
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Malerba, Franco, 2002. "Sectoral systems of innovation and production," Research Policy, Elsevier, vol. 31(2), pages 247-264, February.
- Brigitte van Beuzekom, 2001. "Biotechnology Statistics in OECD Member Countries: Compendium of Existing National Statistics," OECD Science, Technology and Industry Working Papers 2001/6, OECD Publishing.
- Orsenigo, L. & Pammolli, F. & Riccaboni, Massimo, 2001. "Technological change and network dynamics: Lessons from the pharmaceutical industry," Research Policy, Elsevier, vol. 30(3), pages 485-508, March.
- McKelvey, Maureen, 1997. "Coevolution in Commercial Genetic Engineering," Industrial and Corporate Change, Oxford University Press, vol. 6(3), pages 503-532, September.
- Maureen McKelvey & Luigi Orsenigo (ed.), 2006. "The Economics of Biotechnology," Books, Edward Elgar Publishing, volume 0, number 3406, July.
- John Cantwell & Grazia D. Santangelo, 2000. "Capitalism, profits and innovation in the new techno-economic paradigm," Journal of Evolutionary Economics, Springer, vol. 10(1), pages 131-157.
When requesting a correction, please mention this item's handle: RePEc:eee:respol:v:32:y:2003:i:3:p:483-501. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Dana Niculescu)
If references are entirely missing, you can add them using this form.